CYP1A1 alleles in female genital cancers in the Polish population
- PMID: 15653213
- DOI: 10.1016/j.ejogrb.2004.06.036
CYP1A1 alleles in female genital cancers in the Polish population
Abstract
Objective: Cytochrome P4501A1 (CYP1A1) plays an important role in the bioactivation processes that transform aromatic hydrocarbons into ultimate carcinogens. Genetically determined differences in activity of this enzyme could modulate individual susceptibility to develop cancers. The role of CYP1A1 in metabolic pathway of estrogens suggests an influence on carcinogenic events in genital tissues. The aim of our study was to elucidate the possible role of CYP1A1 alleles in the pathogenesis of endometrial and ovarian cancers.
Study design: We have compared CYP1A1 genotype frequency between genital (endometrial and ovarian) cancer groups and 212 healthy women. Cancer patients were stratified using FIGO classification and diagnoses were confirmed histopathologically. The analysis of CYP1A1 genotypes was performed using polymerase chain reaction/restriction fragment length polymorphism (PCR/RFLP) assay.
Results: We have observed higher frequency of heterozygotic genotypes containing mutation m4 (CYP1A1*1/*4) in cancer groups (5.1% in ovarian and 5.6% in endometrial cancer versus 1.9% in controls).
Conclusion: The higher frequency of mutated CYP1A1*4 allele connected with lower frequency of CYP1A1*2A and CYP1A1*2B in endometrial and ovarian cancer groups indicates that differences in the metabolic activity of CYP1A1 could play a significant role in the pathogenesis of genital cancers.
Similar articles
-
An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.Cancer Detect Prev. 2007;31(2):102-9. doi: 10.1016/j.cdp.2007.01.001. Epub 2007 Apr 6. Cancer Detect Prev. 2007. PMID: 17418979
-
A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.Breast Cancer Res Treat. 2007 Jan;101(1):73-81. doi: 10.1007/s10549-006-9264-2. Epub 2006 Jun 29. Breast Cancer Res Treat. 2007. PMID: 16807674
-
Importance of CYP1A1 polymorphism and its transcriptional regulation in ovarian and endometrial cancer.Ginekol Pol. 2011 Dec;82(12):925-32. Ginekol Pol. 2011. PMID: 22384629 Review.
-
Single nucleotide polymorphism of pi-class glutathione s-transferase and susceptibility to endometrial carcinoma.Clin Cancer Res. 2005 Apr 15;11(8):2981-5. doi: 10.1158/1078-0432.CCR-04-2038. Clin Cancer Res. 2005. PMID: 15837751
-
CYP1A1.IARC Sci Publ. 1999;(148):159-72. IARC Sci Publ. 1999. PMID: 10493257 Review.
Cited by
-
Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and ovarian cancer risk: a meta-analysis.Mol Biol Rep. 2012 Nov;39(11):9921-30. doi: 10.1007/s11033-012-1860-0. Epub 2012 Jun 26. Mol Biol Rep. 2012. PMID: 22733497
-
Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes.Carcinogenesis. 2010 May;31(5):827-33. doi: 10.1093/carcin/bgp328. Epub 2010 Jan 6. Carcinogenesis. 2010. PMID: 20053928 Free PMC article.
-
Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention.Biomedicines. 2023 Oct 26;11(11):2898. doi: 10.3390/biomedicines11112898. Biomedicines. 2023. PMID: 38001897 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical